Become A Featured Company

FSD Pharma Takes the Spotlight in CNBC’s Cannabis Coverage

Ryan Allway

October 5th, 2018

News, Top News

Canada is set become the first G7 nation to legalize recreational cannabis and international beverage brands are salivating at the possibilities. Constellation Brands Inc. (NYSE: STZ) doubled down on its investment in Canopy Growth Corp. (NYSE: CGC) (TSX: WEED), Molson Coors Brewing Co. (NYSE: TAP) signed a joint venture with The Hydropothecary Corp. (TSE: HEXO), and even Coca-Cola Co. (NYSE: KO) has taken an interest in the space.

CNBC has ramped up its coverage of the space ahead of Canada’s recreational legalization in less than a month. On September 21, the go-to news source for investors profiled the industry both online and on television. The television producers chose to focus on FSD Pharma Inc. (CSE: HUGE) ( OTCQB: FSDDF) (FRA: 0K9) and visited its Cobourg plant. The location and personnel were featured four times during the day, each with a different area of focus.

In this article, we will take a closer look at the company, its recent CNBC coverage, and where it’s headed over the coming quarters.

Becoming an Industry Leader

FSD Pharma’s renovated 70-acre Kraft facility could become the world’s largest hydroponic cannabis farm, located just one hour east of Toronto. The current 25,000 sq. ft. facility has an annual production capacity of 4,000 kilograms, but management plans to expand to nearly 3.9 million sq. ft. in a two-stage expansion. This would put it just behind behind Canopy Growth and Aurora Cannabis in terms of square footage—at a fraction of their valuation.

Management plans to focus on the medical market as soon as they obtain a sellers’ license, saying that there could be a shortage as other licensed producers move into the recreational market where demand is projected to be initially higher. These dynamics could put a significant premium on medical versus recreational products. Margins from greenhouse strains are also expected to outpace outdoor cannabis products.

CNBC Coverage Raises Profile

The first of the four segments introduces the upcoming Canadian cannabis legalization milestone and features a brief walkthrough of FSD Pharma’s facility. The second segment features an interview with Director Anthony Durkacz. The third segment features a further walkthrough of its facility in Ontario. And, the fourth segment features an extended interview with Anthony on CNBC’s widely watched Power Lunch segment.

The live CNBC coverage bolsters the company’s credibility in the space, particular given the rising number of development-stage licensed producers that can make it challenging for investors to sort true opportunities from hype. Often times, companies featured on CNBC experience higher-than-average trading volume and may be added to important investor watchlists as credible opportunities in the space.

Looking Ahead

FSD Pharma Inc. (CSE: HUGE) ( OTCQB: FSDDF) (FRA: 0K9) represents a compelling investment opportunity in Canada’s burgeoning cannabis sector. In addition to its massive indoor facility, the company’s strategic investments and partnerships across the industry are paving the way for research, development, and distribution throughout the country and around the world.

When asked whether cannabis stocks were in a bubble, Mr. Durkacz drew a comparison to the Internet bubble, telling CNBC, “We are in a bubble — but we were in an internet bubble in 1998 that continued for another few years — if you did not make an investment in 1998, you missed a lion’s share of what could be earned in terms of return on investment.”

Investors that want to buy into the cannabis industry at an early stage may want to take a closer look at the company given its exposure on CNBC, it’s existing license and production capacity, and its unique focus on the medical market.

For more information, visit the company’s website at www.fsdpharma.com.

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading